GlassScriptPhysician profile
Lovrdu Pyreddy
NPI 1952334583
$11,325.41
in general payments reported to CMS, 2019-2025
41 companies · $1,657 in 2025
The $1,657 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,548 · 2020: $1,158 · 2021: $1,498 · 2022: $1,901 · 2023: $1,924 · 2024: $1,639 · 2025: $1,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,214 · Education: $5.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,214.31 |
| Education | $5.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,254.59 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,943.79 | 2019-2025 | Airsupra, Tezspire, Fasenra |
| Philips North America LLC | $1,224.99 | 2019-2025 | Vest Therapy Und, (8874) Incourage |
| Boehringer Ingelheim Pharmaceuticals, INC. | $967.15 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Actelion Pharmaceuticals US, INC. | $522.73 | 2019-2024 | Opsumit, Uptravi |
| Insmed, INC. | $432.30 | 2019-2025 | Arikayce |
| Merck Sharp & Dohme LLC | $351.31 | 2019-2025 | Winrevair, Zerbaxa, Recarbrio |
| Electromed, INC. | $329.36 | 2021-2025 | Smartvest |
| Baxter Healthcare | $301.28 | 2022-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| United Therapeutics Corporation | $297.53 | 2019-2025 | Tyvaso |
| Regeneron Healthcare Solutions, INC. | $242.24 | 2019-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $239.00 | 2021-2022 | |
| Grifols USA, LLC | $238.85 | 2019-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $225.11 | 2020-2025 | |
| Genentech USA, INC. | $188.95 | 2019-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $181.31 | 2019-2021 | |
| Verona Pharma, INC. | $178.92 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $149.48 | 2019 | |
| Mylan Specialty L.P. | $132.01 | 2019-2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $110.58 | 2020-2023 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $92.54 | 2021-2023 | Glassia |
| Paratek Pharmaceuticals, INC. | $86.55 | 2024-2025 | Nuzyra |
| Pulmonx Corporation | $75.30 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Amgen INC. | $57.36 | 2021-2025 | Tezspire |
| Teva Pharmaceuticals USA, INC. | $55.68 | 2019-2022 | |
| Harmony Biosciences LLC | $52.37 | 2022-2023 | Wakix |
| Bayer Healthcare Pharmaceuticals INC. | $47.63 | 2019-2021 | |
| Fisher & Paykel Healthcare INC | $45.93 | 2022-2024 | Fisher & Paykel Healthcare |
| Abbvie INC. | $41.71 | 2021 | |
| Medtronic, INC. | $37.92 | 2021 | |
| Astellas Pharma US INC | $36.88 | 2023-2024 | Cresemba |
| E.R. Squibb & Sons, L.L.C. | $34.18 | 2021-2022 | |
| Circassia INC. | $29.65 | 2019 | |
| Inspire Medical Systems, INC. | $17.84 | 2023 | Inspire |
| Gilead Sciences, INC. | $16.44 | 2019 | |
| Resmed Corp | $15.95 | 2021 | |
| Ceribell, INC. | $15.81 | 2020 | |
| Nabriva Therapeutics, Plc | $15.42 | 2020 | |
| Ani Pharmaceuticals, INC. | $13.76 | 2023 | Purified Cortrophin Gel |
| Pfizer INC. | $13.41 | 2019 | |
| Allergan, INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lovrdu Pyreddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.